The impact of renal dysfunction on early mortality after cardiac surgery: Evaluating the threshold for an unfavorable creatinine clearance and the role of co-morbidities;Über den Einfluss von präoperativen Nierenfunktionsstörungen auf die Letalität nach Herzoperationen. Wo beginnt das Risiko und welche Rolle spielen Begleiterkrankungen?

Clinical Research in Cardiology Supplements

Volumn 2, Issue SUPL.1, 2007, Pages

  Albert, A ^a   Walter, J ^b   Hassanein, W ^a   Ennker, J ^a  

^a Heart Institute Lahr/Baden   (Germany)

^b BIELEFELD UNIVERSITY   (Germany)

Author keywords

cardiac surgery; Creatinine clearance; dialysis; EuroSCORE; Monte Carlo simulation; renal insufficiency

Indexed keywords

EID: 78649510383     PISSN: 18610706     EISSN: 18610714     Source Type: Journal    
DOI: 10.1007/s11789-006-0033-x     Document Type: Article

References (23)

1. Sergeant P, Blackstone E, Meyns B (1997) Validation and interdependence with patient-variables of the influence of procedural variables on early and late survival after CABG. Leuven Coronary Surgery Programm. Euro J Cardiothoracic Surg 12:1-19
2. Rao V, Weisel RD, Buth KJ, Cohen G, Borger MA, Shiono N, Bhatnagar G, Fremes SE, Goldman BS, Christakis GT (1997) Coronary artery bypass grafting in patients with non-dialysis-dependent renal insufficiency. Circulation 96(Suppl 2):II-38-II-43
3. Brown JR, Cochran RP, Dacey LJ, Ross CS, Kunzelman KS, Dunton RF, Braxton JH, Charlesworth DC, Clough RA, Helm RE, Leavitt BJ, Mackenzie TA, O'Connor GT (2006) Northern New England cardiovascular disease study group. Perioperative increases in serum creatinine are predictive of increased 90-day mortality after coronary artery bypass graft surgery. Circulation 114(Suppl 1):I409-I413
4. Nashef S, Roques F, Hammill B, Peterson E, Michel P, Grover F, Wyse R, Ferguson T (2002) Validation of European system for cardiac operative risk evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg 22:101-105
5. Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L (1992) Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. JAMA 6; 267(17):2344-2348
6. Tu JV, Jaglal SB, Naylor CD (1995) Multicenter validation of a risk index for mortality, intensive care unit stay, and overall hospital length of stay after cardiac surgery: steering committee of the provincial adult cardiac care network of ontario. Circulation 91:677-684
7. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(Suppl 1):S1-S266
8. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351:1285-1295
9. Walter J, Mortasawi A, Arnrich B, Albert A, Frerichs I, Rosendahl U, Ennker J (2003) Creatinine clearance versus serum creatinine as a risk factor in cardiac surgery. BMC Surgery 3(4):Internet-Journal (no pages)
10. Arnrich B, Walter J, Albert A, Ennker J, Ritter H (2004) Data mart based research in heart surgery: challenges and benefit. Medinfo, pp 8-12
11. Arnrich B, Albert A, Walter J (2006) Risk stratification of patients with diabetes mellitus undergoing coronary artery bypass grafting-a comparison of statistical methods. Clin Res Cardiol 95(Suppl 1):i14-i17 (in German)
12. Rubin D (1997) Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127(8):757-763
13. Holzmann MJ, Ahnve S, Hammar N, Jorgensen L, Klerdal K, Pehrsson K, Ivert T (2005) Creatinine clearance and risk of early mortality in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 130(3):746-752
14. Hillis G, Croal BL, Buchan KG, El-Shafei H, Gibson G, Jeffrey RG, Millar CGM, Prescott GJ, Cuthbertson BH (2006) Renal function and outcome from coronary artery bypass grafting: impact. Circulation 113:1056-1062
15. Zakeri R, Freemantle N, Barnett V, Lipkin GW, Bonser RS, Graham TR, Rooney SJ, Wilson IC, Cramb R, Keogh BE, Pagano D (2005) Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting. Circulation 112 (Suppl 9): I270-I275
16. Noyez L, Plesiewicz I, Verheugt FW (2006) Estimated creatinine clearance instead of plasma creatinine level as prognostic test for postoperative renal function in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg 29(4):461-465
17. Cooper WA, O'Brien SM, Thourani VH, Guyton RA, Bridges CR, Szczech LA, Petersen R, Peterson ED (2006) Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the society of thoracic surgeons national adult cardiac database. Circulation 113(8):1063-1070
18. Weerasinghe A, Hornick P, Smith P, Taylor K, Ratnatunga C (2001) Coronary artery bypass grafting in nondialysis-dependent mild-to-moderate renal dysfunction. J Thorac Cardiovasc Surg 121(6):1083-1089
19. Wizemann V (1996) Coronary artery disease in dialysis. Nephron 74:642-651
20. Pons J, Espinas J, Borras J, Moreno V, Martin I, Granados A (1998) Cardiac surgical mortality: comparison among different additive risk-scoring models in a multicenter sample. Archives of Surgery 133(10):1053-1057
21. Parsonnet V, Dean D, Berstein AD (1989) A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 79(Suppl 1):I-3-I-12
22. Szczech LA, Best PJ, Crowley E, Brooks MM, Berger PB, Bittner V, Gersh BJ, Jones R, Califf RM, Ting HH, Whitlow PJ, Detre KM, Holmes D, for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators (2002) Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation. Circulation 105: 2253-2258
23. Reddan DN, Szczech L, Tuttle RH, Shaw LK, Jones RH, Schwab SJ, Smith MS, Califf RM, Mark DB, Owen WF Jr (2003) Chronic kidney disease, mortality and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol 14:2373-2380